| 000 | 01046 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516170759.0 | ||
| 264 | 0 | _c20150330 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGosseries, Olivia | |
| 245 | 0 | 0 |
_aAmantadine, apomorphine and zolpidem in the treatment of disorders of consciousness. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2014 |
||
| 300 |
_a4167-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAmantadine _xpharmacokinetics |
| 650 | 0 | 4 |
_aApomorphine _xpharmacokinetics |
| 650 | 0 | 4 |
_aConsciousness Disorders _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPyridines _xpharmacokinetics |
| 650 | 0 | 4 | _aZolpidem |
| 700 | 1 | _aCharland-Verville, Vanessa | |
| 700 | 1 | _aThonnard, Marie | |
| 700 | 1 | _aBodart, Olivier | |
| 700 | 1 | _aLaureys, Steven | |
| 700 | 1 | _aDemertzi, Athena | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 20 _gno. 26 _gp. 4167-84 |
|
| 999 |
_c23077736 _d23077736 |
||